Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
2.430
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed

Soligenix Market Cap

Soligenix has a market cap or net worth of $6.10 million as of February 21, 2025. Its market cap has decreased by -3.21% in one year.

Market Cap
6.10M
Enterprise Value
-1.54M
1-Year Change
-3.21%
Ranking
Category
Stock Price
$2.43

Market Cap Chart

Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $6.10M, a decrease of -75.41%. That is a compound annual growth rate of -5.21%.

History

DateMarket Cap% Change
Feb 21, 20256.10M-10.29%
Dec 31, 20246.80M-13.92%
Dec 29, 20237.90M-59.49%
Dec 30, 202219.50M-31.10%
Dec 31, 202128.30M-25.92%
Dec 31, 202038.20M27.76%
Dec 31, 201929.90M96.71%
Dec 31, 201815.20M-21.65%
Dec 29, 201719.40M128.24%
Dec 30, 20168.50M-72.40%
Dec 31, 201530.80M42.59%
Dec 31, 201421.60M-37.39%
Dec 31, 201334.50M414.93%
Dec 31, 20126.70M1.52%
Dec 30, 20116.60M-83.90%
Dec 31, 201041.00M-11.64%
Dec 31, 200946.40M660.66%
Dec 31, 20086.10M-62.11%
Dec 31, 200716.10M-2.42%
Dec 29, 200616.50M20.44%
Dec 30, 200513.70M-49.07%
Dec 31, 200426.90M-0.37%
Dec 31, 200327.00M167.33%
Dec 31, 200210.10M-22.90%
Dec 31, 200113.10M3.15%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings